Transverse Cervical Nerve for Landmark-Guided Cervical Cutaneous Analgesia
4
item.page.dc.date.issued
2026-01-01
item.page.dc.type
item.page.dc.identifier.issn
0364216X
item.page.dc.identifier.eissn
14325241
item.page.dc.identifier.doi
item.page.dc.identifier.scopus
2-s2.0-105044961602
item.page.oaire.citation.title
Aesthetic Plastic Surgery
item.page.dc.rights.holder
SCOPUS
item.page.dc.identifier.citation
Aesthetic Plastic Surgery (2026)
punsarn.item.page.citation
Yi K.H., Lee S., Jitaree B. Transverse Cervical Nerve for Landmark-Guided Cervical Cutaneous Analgesia. Aesthetic Plastic Surgery (2026). doi:10.1007/s00266-026-06042-4 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/118182
item.page.dc.title
Transverse Cervical Nerve for Landmark-Guided Cervical Cutaneous Analgesia
item.page.dc.contributor.author
item.page.oairecerif.author.affiliation
item.page.dc.contributor.correspondence
item.page.dc.contributor.other
item.page.dc.description.abstract
Background: Neck injections can be painful despite topical anesthesia. Blocking the transverse cervical nerve (TCN) may improve comfort, but clinicians need practical surface landmarks and attention to the external jugular vein (EJV). Methods: In an anatomical mapping series (46 heminecks), the TCN emergence point along the posterior border of the sternocleidomastoid muscle (SCM) was recorded as a percentage of the earlobe-to-lateral clavicular SCM insertion distance (0–100%). In a pilot split-neck study (n=9), the left neck received landmark-guided TCN block with lidocaine at the mapped point (~10 mm depth) before bilateral injections; the right neck received lidocaine 5% cream, applied according to the clinic’s routine protocol for 30 minutes prior to injection Results: The TCN emerged at a mean of 53% along the reference line. Complete cutaneous anesthesia occurred in 9/9 participants (95% CI, 66.4–100%). All participants reported lower VAS pain on the blocked side (sign test, p=0.0039). One bruise occurred (1/9; 11.1%; 95% CI, 0.3–48.2%). Conclusions: A proportional SCM landmark (~53%) provides a simple guide for landmark-based TCN block to reduce discomfort during neck injections. EJV awareness and aspiration are essential for safety. Level of Evidence IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authorswww.springer.com/00266.
